Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 26 Apr 2023
According to researchers from the Karolinska Institutet, patients with Crohn's disease and IBD have an elevated risk of developing lymphoma, and this risk has grown over the past few years.
Read Full NewsThe U.S. FDA issued a warning letter to medical device maker Medline over violations of manufacturing quality standards, the second such action against the company in two...
An intramuscular Masson tumor in the deltoid muscle mimics a malignant vascular tumor on imaging, making surgical excision and histopathologic diagnosis essential.
Ethicist Art Caplan discusses the ethics of healthcare strikes for patients and workers.
Cardiologist Chris Labos takes a look at the French paradox and the J-shaped curve — which tout moderate alcohol as healthy — and asks is the amount of alcohol you should drink really zero?
Drs Ursula A. Matulonis and Stephanie Lheureux discuss the importance of investigator-initiated clinical trials in endometrial cancer, research on carcinosarcoma, and ctDNA.
A skin-mounted ultrasound patch tracks fetal blood flow in real time and may help detect complications in high-risk pregnancies earlier than intermittent scans.
An experimental treatment for spinal cord injuries is drawing patients from as far as Mexico, mobilizing the government to expedite approval before its safety has been proven in a clinical trial.
1.
Molecular profiling of renal medullary carcinoma identifies TROP2 as a promising therapeutic target
2.
In CML Patients With New Diagnoses, STAMP Inhibitor Outperforms Imatinib and Second-Gen TKIs.
3.
Cancer Patients Who Completed Medication Survey Received More Help From Pharmacists
4.
New protocols, according to a study, allow many patients to safely return home one day after lung cancer surgery.
5.
Research Indicates that First-Line Immunotherapy Is Enough for Elderly NSCLC Patients?
1.
The Digital Revolution in Oncology - How Software, AI, and Data are Reshaping Cancer Care by 2025
2.
Obesity as a major risk factor for cancer
3.
Revolutionizing Cancer Treatment with Trilaciclib: How a New Drug is Transforming Outcomes
4.
Spatial Transcriptomics in Oncology: Transforming Tumor Biology and Precision Medicine
5.
Machine Learning in Hematology: Boosting Diagnostic Precision and Speed in Medical Practice
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Navigating the Complexities of Ph Negative ALL - Part III
2.
Navigating the Brain Barrier: The CNS Challenge in ALK+ NSCLC
3.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part V
4.
The Landscape of First-Line Treatment for Urothelial Carcinoma- Further Discussion
5.
Efficient Management of First line ALK-rearranged NSCLC - Part II
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge